3B/BMC asks for investigation of ResMed

Thursday, August 8, 2013

LAKE WALES, Fla. – 3B Medical/BMC Medical, a manufacturer of sleep diagnostics and therapy devices, has requested that the International Trade Commission investigate whether ResMed's action to exclude imports of CPAP devices and interfaces is contrary to the public interest in lowering healthcare costs, according to an Aug. 7 press release. "Because of the economic pressures to reduce healthcare costs, we believe that 3B/BMC plays an important and vital role in bringing lower costs to the sleep disordered breathing market," stated Alex Lucio, vice president, 3B Medical, in the release. "In our view, the litigation by ResMed has little to do with any legitimate intellectual property issues and has more to do with using litigation costs to try and limit competition.” The request is the latest development in the 3B Medical/ResMed patent infringement dispute.